NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
The Latest on: Fecal microbiota transplantation
via Google News
The Latest on: Fecal microbiota transplantation
- Believe it or snot: St. Paul's nasal mucous transplant study targets inflamed sinuses on February 6, 2019 at 10:38 pm
Study leader Dr. Amin Javer said in an interview the inspiration for the chronic rhinosinusitis (CRS) study is the success of fecal transplants ... Sino Nasal Microbiota Transplant (SNMT) study ... […]
- Jury Still Out on Fecal Transplants for Obesity on February 6, 2019 at 8:06 am
Could fecal microbiota transplantation (FMT), whereby medical-processed stool material from a healthy donor is introduced into the intestine of a patient with obesity, be one of the answers to tacklin... […]
- Asia Regulatory Roundup: China’s Communist Party Expels Former Senior Vaccine Regulator for Corruption on February 5, 2019 at 7:39 am
... industry feedback on the regulation of materials used for fecal microbiota transplants. TGA initiated the consultation to answer fundamental questions about fecal transplant materials, such as whe... […]
- A periodic table of your guts is the next step in the race to create a microbiome-feeding poop pill on February 4, 2019 at 10:07 pm
Instead, there is a procedure known as a Fecal Microbiota Transplantation (FMT). This is literally transferring a stool sample from a healthy person to a patient – often via the mouth – so that ‘good’ ... […]
- Fecal transplants, probiotics and the microbiome: What you need to know on January 31, 2019 at 1:46 pm
Fecal microbiota transplantation (FMT) is a therapy in which healthy gut bacteria are delivered from one person to another through the transfer of stool. The transplant is delivered through either ... […]
- Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain on January 31, 2019 at 9:55 am
Furthermore, antibiotics-treated mice showed pain as well as depression-like and anhedonia-like phenotypes, suggesting a role of gut microbiota in these abnormal behaviors. Transplantation of fecal mi... […]
- "Super Poopers" Are Born With an Amazing Ability to Heal Unhealthy Guts on January 27, 2019 at 3:02 am
It’s still not fully clear how fecal transplantation helps, but the general idea is that imbalances in the makeup of the gut microbiota can make people sick, and implanting poop from a healthy person ... […]
- How ‘Poop Transplants’ Help Doctors Treat Intestinal Disorders on January 25, 2019 at 11:23 am
Fecal microbiota transplantation, or poop transplants, are being used to treat a number of chronic bowel conditions, including ulcerative colitis. Share on Pinterest New research may change the way do... […]
- 'Poop Transplants' May Help Ease Painful Colitis on January 22, 2019 at 9:27 am
... microbiome with donor fecal transplant. The new Australian research involved 73 adults with mild to moderate active ulcerative colitis. The patients received a few treatments of low intensity feca... […]
via Bing News